PARIS: Affluent Medical has signed several agreements with Edwards Lifesciences related to Affluent’s structural heart products and technologies. Under the terms of these agreements, Affluent will receive EUR 15 million upfront as a cash payment including; An upfront payment of EUR 5 million for an exclusive option to acquire Kephalios, Affluent’s wholly owned subsidiary supporting…